Enviroxime

This classification denotes an antiviral agent with the molecular formula C17H18N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 133013L556, chemically known as 1h-benzimidazol-2-amine, 6-((hydroxyimino)phenylmethyl)-1-((1-methylethyl)sulfonyl)-, (e)- but generally known as enviroxime, which bears US NIH Compound Identifier 5748733. European Medicines Agency schedules Enviroxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06556MIG. The term ENVIROXIME is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). ENVIROXIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule enviroxime under HS 29350090 and SITC 51580. As of Q4 2014, ENVIROXIME remains the US FDA Preferred Term for this commodity. Enviroxime bears US NLM identifiers UMLS ID C0059396 and NCI Concept Code C83691. SMILES: S(=O)(=O)(N1C2C(NC1N)CCC(C2)/C(=N/O)C1CCCCC1)C(C)C.